Jeng-Feng Lin

405 total citations
23 papers, 315 citations indexed

About

Jeng-Feng Lin is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Epidemiology. According to data from OpenAlex, Jeng-Feng Lin has authored 23 papers receiving a total of 315 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cardiology and Cardiovascular Medicine, 5 papers in Molecular Biology and 4 papers in Epidemiology. Recurrent topics in Jeng-Feng Lin's work include Heart Failure Treatment and Management (4 papers), Cardiovascular Function and Risk Factors (3 papers) and Adipokines, Inflammation, and Metabolic Diseases (3 papers). Jeng-Feng Lin is often cited by papers focused on Heart Failure Treatment and Management (4 papers), Cardiovascular Function and Risk Factors (3 papers) and Adipokines, Inflammation, and Metabolic Diseases (3 papers). Jeng-Feng Lin collaborates with scholars based in Taiwan, United States and China. Jeng-Feng Lin's co-authors include Yu‐Lin Ko, Semon Wu, Ming‐Sheng Teng, Lung‐An Hsu, Hsuan‐Li Huang, Fu‐Tien Chiang, Hsin‐Hua Chou, Su-Man Lin, Hsing-Hui Su and Chun-Lien Chih and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Jeng-Feng Lin

21 papers receiving 307 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeng-Feng Lin Taiwan 12 100 70 69 65 64 23 315
Iram Faqir Muhammad Sweden 13 150 1.5× 99 1.4× 75 1.1× 93 1.4× 77 1.2× 19 430
Yijun Dong China 10 40 0.4× 43 0.6× 33 0.5× 43 0.7× 15 0.2× 35 325
Ziyang Huang China 13 29 0.3× 49 0.7× 99 1.4× 44 0.7× 24 0.4× 34 399
Katerina Koniavitou Greece 8 178 1.8× 66 0.9× 82 1.2× 122 1.9× 16 0.3× 17 482
Necati Dağlı Türkiye 10 153 1.5× 59 0.8× 50 0.7× 122 1.9× 62 1.0× 24 426
Karen Fjeldborg Denmark 7 37 0.4× 137 2.0× 62 0.9× 160 2.5× 12 0.2× 8 373
Rafaela Cavalheiro do Espírito Santo Brazil 10 20 0.2× 109 1.6× 26 0.4× 36 0.6× 125 2.0× 38 353
Kaspar Tootsi Estonia 11 77 0.8× 46 0.7× 20 0.3× 46 0.7× 103 1.6× 23 354
Ronald St-Louis United States 8 56 0.6× 57 0.8× 40 0.6× 31 0.5× 22 0.3× 13 341

Countries citing papers authored by Jeng-Feng Lin

Since Specialization
Citations

This map shows the geographic impact of Jeng-Feng Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeng-Feng Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeng-Feng Lin more than expected).

Fields of papers citing papers by Jeng-Feng Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeng-Feng Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeng-Feng Lin. The network helps show where Jeng-Feng Lin may publish in the future.

Co-authorship network of co-authors of Jeng-Feng Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Jeng-Feng Lin. A scholar is included among the top collaborators of Jeng-Feng Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeng-Feng Lin. Jeng-Feng Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Haixia, Xiao Liang, Lin Lin, et al.. (2025). Koningic acid reduces tumor activity in neuroendocrine prostate cancer by inhibiting glycolysis. Journal of Pharmacology and Experimental Therapeutics. 392(10). 103684–103684.
2.
Yeh, Kun‐Huei, Lung‐An Hsu, Fu‐Tien Chiang, et al.. (2022). Circulating serum amyloid A levels but not SAA1 variants predict long-term outcomes of angiographically confirmed coronary artery disease. Tzu Chi Medical Journal. 34(4). 423–433.
3.
Xu, Zhe, Dou Zhang, Jeng-Feng Lin, et al.. (2021). The influence of CYP2R1 polymorphisms and gene–obesity interaction with hypertension risk in a Chinese rural population. Nutrition Metabolism and Cardiovascular Diseases. 32(1). 241–248. 5 indexed citations
4.
Lin, Jeng-Feng, Semon Wu, Fu‐Tien Chiang, et al.. (2019). Osteoprotegerin and Osteopontin Levels, But Not Gene Polymorphisms, Predict Mortality in Cardiovascular Diseases. Biomarkers in Medicine. 13(9). 751–760. 17 indexed citations
5.
Liu, Peiyu, Chien‐Lin Chen, Yu‐Lin Ko, et al.. (2018). Doses of renin-angiotensin system inhibitors but not beta-blockers predict outcome after ST-elevation myocardial infarction. Acta Clinica Belgica. 74(5). 334–341. 2 indexed citations
6.
Wu, Semon, Ming‐Sheng Teng, Leay‐Kiaw Er, et al.. (2017). Association between NF-κB Pathway Gene Variants and sICAM1 Levels in Taiwanese. PLoS ONE. 12(1). e0169516–e0169516. 7 indexed citations
7.
Hsu, Lung‐An, Semon Wu, Jyh‐Ming Jimmy Juang, et al.. (2017). Growth Differentiation Factor 15 May Predict Mortality of Peripheral and Coronary Artery Diseases and Correlate with Their Risk Factors. Mediators of Inflammation. 2017. 1–13. 34 indexed citations
8.
Lin, Jeng-Feng, Semon Wu, Jyh‐Ming Jimmy Juang, et al.. (2016). IL1RL1 single nucleotide polymorphism predicts sST2 level and mortality in coronary and peripheral artery disease. Atherosclerosis. 257. 71–77. 11 indexed citations
9.
Wu, Semon, Lung‐An Hsu, Ming‐Sheng Teng, et al.. (2016). Interactive effects of C-reactive protein levels on the association between APOE variants and triglyceride levels in a Taiwanese population. Lipids in Health and Disease. 15(1). 94–94. 16 indexed citations
10.
Hsu, Lung‐An, Ming‐Sheng Teng, Jeng-Feng Lin, et al.. (2015). Associations between TRPV4 genotypes and body mass index in Taiwanese subjects. Molecular Genetics and Genomics. 290(4). 1357–1365. 10 indexed citations
11.
Lin, Jeng-Feng, Semon Wu, Ming‐Sheng Teng, et al.. (2015). QT interval Independently Predicts Mortality and Heart Failure in Patients with ST-Elevation Myocardial Infarction. International Journal of Medical Sciences. 12(12). 968–973. 13 indexed citations
12.
Lin, Jeng-Feng, et al.. (2014). Growth-Differentiation Factor-15 and Major Cardiac Events. The American Journal of the Medical Sciences. 347(4). 305–311. 32 indexed citations
13.
Huang, Hsuan‐Li, Semon Wu, Lung‐An Hsu, et al.. (2013). Genetic variants associated with circulating MMP1 levels near matrix metalloproteinase genes on chromosome 11q21-22 in Taiwanese: interaction with obesity. BMC Medical Genetics. 14(1). 30–30. 13 indexed citations
14.
Chang, Shang‐Hung, Jeng-Feng Lin, Yu‐Lin Ko, et al.. (2013). Correlates of Impaired Global Right Ventricular Function in Patients with a Reperfused Acute Myocardial Infarction and without Right Ventricular Infarction. Journal of Investigative Medicine. 61(4). 715–721. 11 indexed citations
15.
Wu, Semon, Lung‐An Hsu, Ming‐Sheng Teng, et al.. (2012). Association of SELE genotypes/haplotypes with sE-selectin levels in Taiwanese individuals: interactive effect of MMP9 level. BMC Medical Genetics. 13(1). 115–115. 8 indexed citations
16.
Lin, Jeng-Feng, et al.. (2012). Resveratrol Protects Left Ventricle by Increasing Adenylate Kinase 1 and Isocitrate Dehydrogenase Activities in Rats with Myocardial Infarction. The Chinese Journal of Physiology. 54(6). 406–12. 10 indexed citations
17.
Lin, Jeng-Feng, et al.. (2011). Right Ventricular Function in Patients With Different Infarction Sites After a First Acute Myocardial Infarction. The American Journal of the Medical Sciences. 342(6). 474–479. 16 indexed citations
18.
19.
Lin, Jeng-Feng, et al.. (2008). Resveratrol reduces infarct size and improves ventricular function after myocardial ischemia in rats. Life Sciences. 83(9-10). 313–317. 50 indexed citations
20.
Lin, Jeng-Feng, et al.. (2005). An early diagnosis leads to a good prognosis: a patient with maple syrup urine disease--screened by tandem mass spectrometry.. PubMed. 45(5). 287–9. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Iram Faqir Muhammad Breakdown of academic impact, for papers by Yijun Dong Breakdown of academic impact, for papers by Ziyang Huang Breakdown of academic impact, for papers by Katerina Koniavitou Breakdown of academic impact, for papers by Necati Dağlı Breakdown of academic impact, for papers by Karen Fjeldborg Breakdown of academic impact, for papers by Rafaela Cavalheiro do Espírito Santo Breakdown of academic impact, for papers by Kaspar Tootsi Breakdown of academic impact, for papers by Ronald St-Louis
Rankless by CCL
2026